Vitality Biopharma

(OTC: VBIO)
Healthcare  |  Biotechnology
0.10 -0.039 -27.86%
Stock Price | Oct. 22, 2019, 3:43 p.m.
1 Follower
Bid:
Ask:
Prev. Close: 0.14
52 Week Low: 1e-05
52 Week High: 1.77
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Vitality Biopharma Inc is engaged in the development of cannabinoid prodrug pharmaceuticals. Vitality Biopharma has developed a new class of cannabinoid prodrugs, known as cannabosides, which upon ingestion can enable the selective delivery of THC and cannabidiol (CBD) to the gastrointestinal tract. It develops cannabinoid product named VITA-100. VITA-100 is an oral cannabinoid formulation containing cannabosides that is being developed for the acute treatment of inflammatory bowel disease and narcotic bowel syndrome.

Read more Read less

Recently Viewed Tickers

Premium Cannabis Stocks Review - Weekend Edition 03/05/18

52 Comments
1 year ago

Premium Cannabis Stocks Review - Pre-Market Edition 03/02/18

36 Comments
1 year ago

Premium Cannabis Stocks Review - Weekend Edition 02/26/18

32 Comments
1 year ago

Premium Cannabis Stocks Review - Weekend Edition 02/20/18

113 Comments
1 year ago

Premium Cannabis Stocks Review - Pre-Market Edition 02/15/18

3 Comments
1 year ago

Premium Cannabis Stocks Review - Weekend Edition 02/12/18

30 Comments
1 year ago

Premium Cannabis Stocks Review - AM Edition 02/07/18

37 Comments
1 year ago

Premium Cannabis Stocks Review - Weekend Edition 02/05/18

18 Comments
1 year ago

Premium Cannabis Stocks Review - AM Edition 01/29/18

14 Comments
1 year ago

Premium Cannabis Stocks Review - Weekend Edition 01/29/18

48 Comments
1 year ago